If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.
We set cookies so you can manage your account and navigate the site, and to remember your cookie preferences so that you don't keep getting this message. To accept cookies, just keep browsing, otherwise use the links on the right to adjust your cookie settings or find out more.
There's something seriously wrong with our drug approval processes. One in three drugs that pass all the usual checks before being given a licence are unsafe, and are causing serious—and sometimes deadly—health reactions in patients.
New 'breakthrough' drugs are often being allowed onto the market as safe and effective treatments with minimal evidence—and drug companies are failing to provide any good research even five years after the drugs have been approved, a new study has found.
Young and pregnant women are being warned not to take the epilepsy drug valproate—marketed as Epilim, Depakine, Depakote and Stavzor—because it's likely to cause birth defects in the newborn. 'Serious malformations' have been reported in up to 4,100 children born in France alone.
Low back pain is one of the most common ailments, and half of those afflicted suffer with it their entire adult lives—but conventional medicine has no real answer.
Fat-soluble vitamins can make antibiotics effective against superbugs, so-named because they have become resistant to the drugs.